CVS Health Trades at 11x Forward Earnings with 3.46% Yield, $402B 2025 Revenue
CVS Health trades at 11x forward earnings with a 3.46% dividend yield and posted record $402.1 billion 2025 revenue alongside 24.5% adjusted EPS growth. Management forecasts continued mid-teens earnings gains supported by a higher Medicare payment rate and cost synergies from its integrated pharmacy, insurance and clinic operations.
1. Valuation Metrics
CVS Health shares trade at 11x forward earnings, below many healthcare peers, while offering a 3.46% dividend yield that ranks among the highest in the integrated healthcare sector.
2. 2025 Financial Performance
The company achieved record 2025 revenue of $402.1 billion and delivered 24.5% adjusted EPS growth, reflecting strong demand across its pharmacy services, Aetna insurance business and HealthHUB clinics.
3. Growth Outlook
Management projects mid-teens percentage earnings growth over the coming years, leveraging scale benefits and operational efficiencies from its combined pharmacy, insurance and health services platforms.
4. Medicare Rate Impact & Synergies
A favorable increase in Medicare payment rates is expected to bolster revenue, while cost synergies from shared technology, procurement and cross-selling between clinics and insurance boost long-term margins.